Operating cash flow consistently exceeds net income with a 10-quarter average OCF/NI ratio of 1.64, yet free cash flow is volatile, ranging from -4.8% to 19.7% of revenue, as aggressive deployment for acquisitions ($52.5M) and shareholder returns ($53.7M) has depleted cash reserves to $24.9M.
U.S. Physical Therapy, Inc. (USPH) cash flow statement — 30-year operating, investing & financing cash flows
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Cash from Operations | 87.05M | 75.06M | 74.94M | 81.98M | 58.54M | 76.41M | 100M | 62.45M | 73M | 56.53M | 51.05M | 41.24M | 45.19M | 44.8M | 39.25M | 32.66M | 30.52M | 30.94M | 30.17M | 19.05M | 18.47M | 18.25M | 17.88M | 17.53M | 19.52M | 15.17M | 8.86M | 5.05M | 5M | 3.8M | 4.7M |
| Operating CF Margin % | - | 9.61% | 11.16% | 13.55% | 10.58% | 15.43% | 23.64% | 12.96% | 16.08% | 13.65% | 14.32% | 12.45% | 14.81% | 16.96% | 15.57% | 13.78% | 14.45% | 15.36% | 16.08% | 12.56% | 13.66% | 13.81% | 15.12% | 16.61% | 20.61% | 18.74% | 14.02% | 10.11% | 11.36% | 9.79% | 14.6% |
| Operating CF Growth % | 213.74% | 0.16% | -8.59% | 40.04% | -23.39% | -23.59% | 60.13% | -14.46% | 29.15% | 10.73% | 23.78% | -8.74% | 0.89% | 14.13% | 20.19% | 6.99% | -1.37% | 2.56% | 58.41% | 3.11% | 1.21% | 2.06% | 2.01% | -10.2% | 28.68% | 71.22% | 75.47% | 1% | 31.58% | -19.15% | 95.83% |
| Net Income | 2.26M | 58.01M | 45.6M | 37.22M | 43.41M | 57.92M | 52.49M | 57.26M | 48.84M | 27.72M | 26.27M | 31.69M | 30.42M | 21M | 26.22M | 29.78M | 24.7M | 19.97M | 10M | 8.74M | 6.3M | 8.79M | 6.68M | 7.33M | 8.49M | 7.07M | 3.73M | 2.39M | 1.6M | 2.4M | 1.6M |
| Depreciation & Amortization | 28.4M | 22.39M | 18.68M | 15.7M | 14.74M | 11.59M | 10.53M | 10.1M | 9.76M | 9.71M | 8.78M | 7.95M | 6.74M | 5.56M | 5.29M | 5.45M | 5.67M | 5.9M | 5.97M | 4.99M | 4.49M | 4.31M | 4.32M | 3.59M | 2.96M | 2.57M | 2.33M | 2.09M | 2.1M | 1.9M | 1.7M |
| Stock-Based Compensation | 9.86M | 8.27M | 7.82M | 7.24M | 7.26M | 7.87M | 7.92M | 6.99M | 5.94M | 5.03M | 4.96M | 4.49M | 3.36M | 2.74M | 2.1M | 2.03M | 1.29M | 1.57M | 1.57M | 1.28M | 1.04M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 12.65M | 11.41M | 5.37M | 4.49M | 4.31M | 5.69M | -258K | 4.65M | 4.81M | -4.55M | 2.98M | 7M | 6.28M | 2.37M | 3.74M | 3.83M | 452K | 714K | 1.92M | 313K | -373K | 44K | 146K | 474K | -319K | -351K | 0 | 0 | 300K | 0 | 0 |
| Other Non-Cash Items | 29.56M | 2.18M | 9.88M | 22.27M | 10.24M | 5.12M | 5.67M | -560K | 2.92M | 4.29M | 4.19M | 3.49M | 3.33M | 11.02M | 6.37M | -1.25M | 2.16M | 2.93M | 9.93M | 7.84M | 8.16M | 7.06M | 7.79M | 8.01M | 10.83M | 10.25M | 5.35M | 3.75M | -100K | 2.8M | 2.1M |
| Working Capital Changes | -37.88M | -27.19M | -12.4M | -4.93M | -21.43M | -11.78M | 23.64M | -15.98M | 732K | 14.32M | 3.87M | -13.38M | -4.94M | 2.1M | -4.47M | -7.19M | -3.75M | -148K | 772K | -4.11M | -1.15M | -1.95M | -1.05M | -1.87M | -2.43M | -4.36M | -2.56M | -3.19M | -2.1M | -3.3M | -700K |
| Change in Receivables | -7.67M | -9.06M | -11.89M | -6M | -10.28M | -10.96M | 2.56M | -6.38M | -3.43M | -3.45M | -3.27M | -5.52M | -5.39M | -5.39M | -1.66M | -6.14M | -4.47M | -303K | -1.57M | -3.54M | -3.43M | -3.22M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.21M | -742K | -794K | -1.45M | -2.33M | -2.15M | 1.8M | -1.15M | 0 | -24.04M | -19.97M | 252K | -87K | -73K | -29.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -8.88M | -7.8M | 0 | 15K | -7.75M | 0 | 0 | -4.21M | 4.88M | 6.98M | 2.99M | -7.01M | 1.87M | 4.83M | -340K | 1.19M | -292K | 1.87M | 1.87M | -655K | 1.62M | 1.04M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -103.58M | -36.71M | -149.45M | -45.02M | -81.27M | -124.14M | -51.2M | -37.99M | -23.91M | -43.58M | -32.49M | -32.24M | -22.88M | -52.45M | -14.1M | -31.61M | -21.63M | -7.33M | -24.88M | -23.54M | -8.85M | -12.18M | -4.96M | -5.03M | -6.63M | -3.38M | -2.8M | -2.1M | -2.5M | -2.1M | -2M |
| Capital Expenditures | -24.35M | -14.07M | -9.19M | -9.29M | -8.25M | -8.2M | -7.64M | -10.19M | -7.19M | -7.09M | -8.26M | -6.26M | -5.17M | -4.64M | -4.23M | -3.22M | -3.67M | -3.88M | -4.3M | -4.03M | -4.66M | -10.85M | -4.97M | -5.13M | -5.57M | -3.34M | -2.83M | -2.1M | -2.4M | -1.8M | -2M |
| CapEx % of Revenue | 3.46% | 1.8% | 1.37% | 1.54% | 1.49% | 1.66% | 1.81% | 2.11% | 1.58% | 1.71% | 2.32% | 1.89% | 1.69% | 1.76% | 1.68% | 1.36% | 1.74% | 1.92% | 2.29% | 2.66% | 3.44% | 8.21% | 4.2% | 4.86% | 5.87% | 4.13% | 4.47% | 4.2% | 5.45% | 4.64% | 6.21% |
| Acquisitions | -66.29M | -24.95M | -142.04M | -36.87M | -74.28M | -116.09M | -43.56M | -27.87M | -16.37M | -36.56M | -24.29M | -26.05M | -17.76M | -48.5M | -10.17M | -9.45M | -17.28M | -1.18M | -20.68M | -20.02M | -5.21M | -1.51M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -12.95M | 2.31M | 1.77M | 1.15M | 1.26M | 152K | 0 | 64K | -349K | 81K | 61K | 71K | 5.54M | 2.33M | 303K | -18.93M | -17.96M | 57K | 108K | 21K | -1.14M | 178K | 11K | 105K | -1.07M | -32K | 25K | 1K | -100K | -300K | 0 |
| Cash from Financing | 199K | -44.14M | -36.95M | 84.27M | 25.76M | 43.38M | -39.42M | -24.27M | -47.66M | -11.06M | -14.29M | -7.5M | -20.94M | 8.88M | -23.46M | -245K | -6.14M | -27.3M | -3.16M | 1.51M | -11.03M | -11.62M | -9.19M | -3.29M | -13.4M | -5.75M | -8.02M | -5.25M | -1.7M | -1.1M | -500K |
| Debt Issued (Net) | 102M | 8.06M | 4.3M | -39.15M | 64.19M | 93.1M | -31.04M | 6.57M | -20.04M | 6.77M | 1.2M | 8.62M | -6.33M | 22.14M | -6.53M | 17.75M | 4.09M | -12.38M | 3.51M | 6.41M | -245K | -153K | -52K | -38K | -701K | -1.54M | 862K | -32K | -100K | -100K | 200K |
| Equity Issued (Net) | -24.8M | -5.57M | 0 | 163.65M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.66M | -1.4M | -5.59M | 495K | 568K | -5.4M | -6.2M | -3.81M | 1.44M | -7.51M | 336K | -5.88M | -3.28M | 0 | 0 | 0 |
| Dividends Paid | -27.55M | -27.36M | -26.54M | -24.13M | -21.32M | -18.77M | -4.11M | -14.55M | -11.66M | -10.07M | -8.51M | -7.45M | -5.87M | -4.84M | -9.02M | -3.79M | -9.58M | -9.44M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -24.8M | -5.57M | 0 | 0 | 0 | 0 | 0 | 502K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.66M | -1.4M | -5.59M | 0 | 0 | -5.52M | -8M | -5.58M | -20K | -10.51M | -1.94M | -6.28M | -3.41M | 0 | 0 | 0 |
| Other Financing | -49.44M | -19.27M | -14.71M | -16.1M | -17.11M | -30.96M | -4.28M | -16.29M | -15.95M | -7.77M | -6.98M | -4.94M | -8.74M | -8.42M | -7.91M | -9.55M | -8.82M | 101K | 128K | -5.47M | -5.38M | -5.27M | -5.33M | -4.7M | -5.19M | -4.54M | -3M | -1.94M | -1.6M | -1M | -700K |
| Net Change in Cash | -16.33M | -5.79M | -111.46M | 121.23M | 3.03M | -4.35M | 9.37M | 180K | 1.44M | 1.89M | 4.27M | 1.51M | 1.37M | 1.23M | 1.69M | 804K | 2.75M | -3.68M | 2.14M | -2.98M | -1.4M | -5.55M | 3.73M | 9.21M | -511K | 6.05M | -1.96M | -2.3M | 800K | 600K | 2.2M |
| Free Cash Flow | 62.7M | 60.99M | 65.75M | 72.68M | 50.29M | 68.2M | 92.36M | 52.26M | 65.81M | 49.43M | 42.79M | 34.98M | 40.03M | 40.16M | 35.02M | 29.43M | 26.85M | 27.07M | 25.87M | 15.01M | 13.82M | 7.4M | 12.91M | 12.4M | 13.96M | 11.83M | 6.03M | 2.95M | 2.6M | 2M | 2.7M |
| FCF Margin % | 8.9% | 7.81% | 9.79% | 12.02% | 9.09% | 13.78% | 21.84% | 10.84% | 14.5% | 11.94% | 12% | 10.56% | 13.12% | 15.21% | 13.89% | 12.42% | 12.71% | 13.44% | 13.79% | 9.9% | 10.22% | 5.6% | 10.92% | 11.74% | 14.73% | 14.61% | 9.54% | 5.91% | 5.91% | 5.15% | 8.39% |
| FCF Growth % | 3% | -7.25% | -9.53% | 44.53% | -26.27% | -26.15% | 76.73% | -20.59% | 33.14% | 15.52% | 22.33% | -12.61% | -0.33% | 14.69% | 18.97% | 9.63% | -0.81% | 4.62% | 72.34% | 8.66% | 86.62% | -42.67% | 4.15% | -11.18% | 18.02% | 96.02% | 104.33% | 13.58% | 30% | -25.93% | 200% |
| FCF per Share | 4.15 | 4.02 | 4.36 | 5.12 | 3.87 | 5.29 | 7.20 | 4.10 | 5.20 | 3.93 | 3.42 | 2.82 | 3.28 | 3.32 | 2.94 | 2.46 | 2.26 | 2.29 | 2.15 | 1.28 | 1.18 | 0.61 | 1.04 | 1.03 | 1.10 | 0.92 | 0.56 | 0.30 | 0.24 | 0.18 | 0.26 |
| FCF Conversion (FCF/Net Income) | 27.71x | 4.98x | 2.83x | 5.59x | 2.07x | 2.75x | 3.27x | 2.22x | 7.23x | 2.54x | 2.48x | 1.85x | 2.29x | 3.52x | 2.19x | 1.56x | 1.95x | 2.63x | 3.02x | 2.14x | 2.93x | 2.08x | 2.68x | 2.39x | 2.30x | 2.15x | 2.37x | 2.11x | 3.13x | 1.58x | 2.94x |
| Interest Paid | 2.62M | 9.43M | 7.21M | 8.65M | 5.69M | 1.35M | 1.2M | 1.89M | 2.36M | 2.11M | 784K | 884K | 1.1M | 352K | 639K | 325K | 179K | 324K | 484K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 1.98M | 14.35M | 4.83M | 4.93M | 7.62M | 12.21M | 7.68M | 9.86M | 9.18M | 8.54M | 10.58M | 7.78M | 9.25M | 4.11M | 6.36M | 9.04M | 7.8M | 8.45M | 4.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying USPH stock.
U.S. Physical Therapy, Inc. (USPH) generated $75.1M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
U.S. Physical Therapy, Inc. (USPH) generated $61.0M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
U.S. Physical Therapy, Inc. (USPH) spent $14.1M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, U.S. Physical Therapy, Inc. (USPH) returned $27.4M to shareholders via cash dividends and spent $5.6M on share repurchases. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
Cash flow volatility masking earnings
Metrics are mathematically derived from official filings.
Earnings Quality Masked by Cash Conversion
Operating cash flow consistently and significantly exceeds net income, with a 10-quarter average OCF/NI ratio of 1.64, suggesting strong cash conversion quality and substantial non-cash charges like depreciation and SBC bolstering cash generation, as indicated by reported financial results.
The persistent gap between net income and operating cash flow indicates the business model generates far more cash than GAAP profits suggest, primarily due to depreciation and share-based compensation. This pattern implies the net loss in Q1 2026 may not reflect underlying cash profitability, though investors should monitor if this conversion quality holds during periods of severe working capital pressure.
Volatile FCF Trajectory Undermines Earnings
Free cash flow has swung wildly from -$7.3M in Q1 2025 to $31.6M in Q2 2025, with the FCF margin ranging from -4.8% to 19.7%, indicating a volatile trajectory that decouples from the more stable, though recently negative, net income trend, as per the company's quarterly disclosures.
This volatility suggests FCF is driven more by timing of working capital and acquisition payments than by underlying operational profitability. The decoupling from net income means recent net losses do not necessarily signal cash burn, but the erratic trajectory creates significant uncertainty for forecasting sustainable free cash generation.
Working Capital Drains Destroy Cash
Working capital consumed $74.4M over the last ten quarters, with massive outflows of $28.3M and $19.4M in Q1 2025 and Q1 2026 respectively, representing a primary source of cash flow volatility that appears to overwhelm operating profitability, based on the provided cash flow statements.
The persistent negative working capital changes indicate the company may be struggling to collect receivables or is prepaying expenses, a pattern that severely undermines cash generation. These drains are likely seasonal but their magnitude suggests a structural issue in managing the cash conversion cycle, directly contradicting any positive signals from operating income.
Aggressive Deployment Limits Cash Accumulation
Capital deployment has been aggressive, with $52.5M spent on acquisitions and $53.7M on dividends and buybacks over the last ten quarters, which has consumed the majority of generated operating cash flow and limited the net cash position despite strong OCF, according to the company's reported financing activities.
Management's commitment to shareholder returns via dividends and a recent $19.2M buyback in Q2 2026, alongside significant M&A, suggests a strategy of aggressive capital deployment rather than cash accumulation. This approach leaves limited buffer to fund operations or absorb further working capital shocks, heightening financial risk.
SBC and Acquisition Distortions
Reported operating cash flow includes $13.6M of stock-based compensation over four quarters, a non-cash add-back, while the $93.4M acquisition in Q4 2024 and subsequent deals significantly distort cash flow from operations and investing, potentially obscuring the underlying organic cash generation ability, as seen in the financial statements.
SBC, while non-cash, represents real dilution and future cash obligations, making it a critical adjustment for true cash earnings analysis. Furthermore, the large acquisition spending obscures the maintenance cash needs of the business, making it difficult to assess whether operating cash flow is sufficient to fund both growth and normal capital replacement.